Sign In
Buy HOOK
Hookipa Pharma Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -62.50. In total, the insiders bought 10.58M and sold 135.91K HOOK shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-62.50 |
| ● Buy | 10.58M shares |
| ● Sell | 135.91K shares |
|
94% Buy Activity
Moderate Positive Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Apr 14, 2023 Buy |
Kandera Reinhard Chief Financial Officer |
214 800 Value: $214.8K |
||
|
Apr 14, 2023 Buy |
Baker Christine D. Chief Operating Officer |
275 800 Value: $275.8K |
||
|
Apr 14, 2023 Buy |
Schlienger Katia Chief Medical Officer |
184 000 Value: $184.0K |
||
|
Apr 14, 2023 Buy |
Necina Roman Chief Development Officer |
112 100 Value: $112.1K |
||
|
Apr 14, 2023 Buy |
Orlinger Klaus Chief Scientific Officer |
194 200 Value: $194.2K |
||
|
Apr 03, 2023 Buy |
Coelho Mary Theresa |
0 Value: $0 |
||
|
Apr 03, 2023 Buy |
Coelho Mary Theresa |
0 Value: $0 |
||
|
Mar 09, 2023 Buy |
Schlienger Katia Chief Medical Officer |
0 Value: $0 |
||
|
Mar 09, 2023 Buy |
Schlienger Katia Chief Medical Officer |
27 952 Value: $335.4K |
||
|
Mar 09, 2023 Buy |
Schlienger Katia Chief Medical Officer |
17 760 Value: $29.5K |
||
|
Mar 09, 2023 Buy |
Schlienger Katia Chief Medical Officer |
17 760 Value: $29.5K |
||
|
Mar 09, 2023 Buy |
Schlienger Katia Chief Medical Officer |
27 952 Value: $335.4K |
||
|
Mar 09, 2023 Buy |
Schlienger Katia Chief Medical Officer |
0 Value: $0 |
||
|
Jan 01, 2023 Buy |
Peters Malte |
0 Value: $0 |
||
|
Jan 01, 2023 Buy |
Peters Malte |
0 Value: $0 |
||
|
Jun 30, 2022 Buy |
Van De Winkel Jan |
40 000 Value: $0 |
||
|
Jun 30, 2022 Buy |
Van De Winkel Jan Director |
40 000 Value: $65.2K |
||
|
Jun 30, 2022 Buy |
Reilly Timothy P. |
40 000 Value: $0 |
||
|
Jun 30, 2022 Buy |
Orlinger Klaus Chief Scientific Officer |
48 350 Value: $0 |
||
|
Jun 30, 2022 Buy |
Orlinger Klaus Chief Scientific Officer |
48 350 Value: $80.3K |
||
|
Jun 30, 2022 Buy |
Aldag Jorn Chief Executive Officer |
275 250 Value: $456.9K |
||
|
Jun 30, 2022 Buy |
Aldag Jorn Chief Executive Officer |
275 250 Value: $0 |
||
|
Jun 30, 2022 Buy |
Baker Christine D. Chief Operating Officer |
100 000 Value: $0 |
||
|
Jun 30, 2022 Buy |
Kandera Reinhard Chief Financial Officer |
92 950 Value: $154.3K |
||
|
Jun 30, 2022 Buy |
Kandera Reinhard Chief Financial Officer |
92 950 Value: $0 |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
